Ampicillin-improved glucose tolerance in diet-induced obese C57BL/6NTac mice is age dependent

Ida Rune, Camilla Hartmann Friis Hansen, Merete Ellekilde, Dennis Sandris Nielsen, K. Skovgaard, B.C. Rolin, Jens Lykkesfeldt, K. Josefsen, Britt Tranberg Christensen, Pernille Kihl, Axel Jacob Kornerup Hansen

21 Citations (Scopus)
1791 Downloads (Pure)

Abstract

Ampicillin has been shown to improve glucose tolerance in mice. We hypothesized that this effect is present only if treatment is initiated prior to weaning and that it disappears when treatment is terminated. High-fat fed C57BL/6NTac mice were divided into groups that received Ampicillin at different ages or not at all. We found that both diet and Ampicillin significantly changed the gut microbiota composition in the animals. Furthermore, there was a significant improvement in glucose tolerance in Ampicillin-treated, five-week-old mice compared to nontreated mice in the control group. At study termination, expressions of mRNA coding for tumor necrosis factor, serum amyloid A, and lactase were upregulated, while the expression of tumor necrosis factor (ligand) superfamily member 15 was downregulated in the ileum of Ampicillin-treated mice. Higher dendritic cell percentages were found systemically in high-fat diet mice, and a lower tolerogenic dendritic cell percentage was found both in relation to high-fat diet and late Ampicillin treatment. The results support our hypothesis that a "window" exists early in life in which an alteration of the gut microbiota affects glucose tolerance as well as development of gut immunity and that this window may disappear after weaning.

Original languageEnglish
Article number319321
JournalExperimental Diabetes Research
Volume2013
Number of pages13
ISSN1687-5214
DOIs
Publication statusPublished - 2013

Fingerprint

Dive into the research topics of 'Ampicillin-improved glucose tolerance in diet-induced obese C57BL/6NTac mice is age dependent'. Together they form a unique fingerprint.

Cite this